Alembic Pharmaceuticals Ltd
NSE:APLLTD

Watchlist Manager
Alembic Pharmaceuticals Ltd Logo
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Watchlist
Price: 1 028 INR 0.83%
Market Cap: 202.1B INR
Have any thoughts about
Alembic Pharmaceuticals Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
Alembic Pharmaceuticals Ltd

Rotate your device to view
Cash Flow Statement
Currency: INR
Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024
Operating Cash Flow
Net Income
9 998
12 998
13 681
9 930
6 201
3 301
3 546
5 262
6 318
Depreciation & Amortization
1 573
1 712
1 835
2 060
2 868
3 138
2 754
2 744
2 727
Other Non-Cash Items
1 210
734
(823)
(443)
1 363
2 649
2 122
507
142
Cash Taxes Paid
2 361
2 593
2 454
2 009
1 234
944
607
264
199
Cash Interest Paid
1 111
987
729
514
519
754
497
517
494
Change in Working Capital
(8 290)
(3 067)
(59)
(3 240)
(4 908)
(2 335)
(1 183)
(2 485)
(1 155)
Cash from Operating Activities
4 491
N/A
12 378
+176%
14 634
+18%
8 306
-43%
5 524
-33%
6 754
+22%
7 240
+7%
6 028
-17%
8 032
+33%
Investing Cash Flow
Capital Expenditures
(7 349)
(6 168)
(6 595)
(6 542)
(4 256)
(3 858)
(4 434)
(3 985)
(3 275)
Other Items
33
37
(1 793)
(1 870)
537
517
(42)
165
69
Cash from Investing Activities
(7 316)
N/A
(6 131)
+16%
(8 388)
-37%
(8 412)
0%
(3 720)
+56%
(3 342)
+10%
(4 476)
-34%
(3 820)
+15%
(3 206)
+16%
Financing Cash Flow
Net Issuance of Common Stock
0
7 341
7 341
0
0
0
0
0
0
Net Issuance of Debt
1 605
(3 308)
(3 980)
2 305
1 098
(1 767)
(172)
642
(2 312)
Cash Paid for Dividends
(3 260)
(2 010)
0
(2 752)
(2 752)
(1 966)
(1 966)
(1 572)
(1 573)
Other
3 203
(6 302)
(9 335)
(980)
(520)
(282)
(482)
(517)
(494)
Cash from Financing Activities
1 549
N/A
(4 278)
N/A
(5 974)
-40%
(1 427)
+76%
(2 174)
-52%
(4 015)
-85%
(2 620)
+35%
(1 447)
+45%
(4 379)
-203%
Change in Cash
Effect of Foreign Exchange Rates
4
(63)
(9)
57
0
2
(0)
(0)
0
Net Change in Cash
(1 272)
N/A
1 906
N/A
263
-86%
(1 476)
N/A
(370)
+75%
(601)
-62%
144
N/A
760
+428%
447
-41%
Free Cash Flow
Free Cash Flow
(2 858)
N/A
6 210
N/A
8 039
+29%
1 764
-78%
1 268
-28%
2 896
+128%
2 806
-3%
2 043
-27%
4 757
+133%

See Also

Discover More